Signaling Pathways - Insulin and Insulin-like Receptors - Protease-Activated Receptors - Mixed lineage kinase domain-like protein (MLKL) - HER2
清除全部
- B7731 Necrosulfonamide1 CitationTarget: Mixed lineage kinase domain-like protein (MLKL)Summary: 坏死抑制剂
- A8809 Vorapaxar中文名: 沃拉帕沙Target: Protease-Activated ReceptorsSummary: PAR-1拮抗剂
- A8528 TAK-285Target: EGFR|HER2Summary: HER2/EGFR(HER1)抑制剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A8366 ARRY-380Target: HER2Summary: 酪氨酸激酶HER2和P95-HER2抑制剂。
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A8229 ML161Target: Protease-Activated ReceptorsSummary: PAR1抑制剂
- A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂
- A3145 Afatinib dimaleate中文名: 马来酸阿法替尼Target: EGFR|HER2Summary: EGFR抑制剂